26 Apr Bio-Me Joins Microbiome Therapeutics Innovation Group

OSLO, Norway, April 26, 2022 – The Microbiome Therapeutics Innovation Group (MTIG) yesterday announced the addition of Bio-Me to its coalition of companies leading the research and development of FDA-approved microbiome therapeutic drugs and microbiome-based products.

Read the full press release under https://www.prnewswire.com/news-releases/bio-me-joins-microbiome-therapeutics-innovation-group-301531803.html?tc=eml_cleartime.